Abstract Expression of the receptor tyrosine kinase HER3 is negatively correlated with survival in ovarian cancer, and HER3 overexpression is associated with cancer progression and therapeutic resistance. Thus, improvements in HER3-targeted therapy could lead to significant clinical impact for ovarian cancer patients. Previous work from our group established multivalency as a potential strategy to improve the therapeutic efficacy of HER3-targeted ligands, including affibodies....
By Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete,Greece,00302841026182,00306932607174
Labels
Subscribe to:
Post Comments (Atom)
Collaboration request
Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...
-
Secondary Traumatic Stress in Nursing: A Walker and Avant Concept Analysis Nurses on the front lines of health care are impacted psychologic...
-
Cystic Lesion in the Fetal Scalp: A Systematic Approach Abstract During an anomaly scan, cystic lesion in the scalp may be encountered while...
No comments:
Post a Comment